{"anticipatedPostingDate":"2010-07","classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"13.3","value":"4.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"}],"units":"Participants"}],"description":"Percent overall survival (actuarial) at analysis in Dec 2011.","dispersionType":"95% Confidence Interval","groups":[{"description":"Ex vivo selective depletion of alloreactive donor T lymphocytes utilizing RFT5-SMPT-dgA, a specific anti-interleukin-2 receptor immunotoxin in HLA-matched, nonmyeloablative, peripheral blood stem cell transplantation for hematologic malignancies in older adults","id":"OG000","title":"RFT5-SMPT-dgA, an Anti-interleukin, Used in Transplants"}],"paramType":"NUMBER","populationDescription":"all patients who received the selectively depleted transplant including one special exemption","reportingStatus":"POSTED","timeFrame":"Dec 2011.","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"percentage of participants"}